Condensed Consolidated Statements Of Operations (USD $)	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Net revenues:
Product revenue	$ 7,020,188	$ 7,472,582
Other revenue	0	6,934
Revenues, net	7,020,188	7,479,516
Costs and expenses:
Cost of goods sold	3,975,591	4,362,215
Marketing, general and administrative	3,370,554	3,570,261
Research and development	381,943	396,228
Total costs and expenses	7,728,088	8,328,704
Loss from operations	(707,900)	(849,188)
Other (expense) and income:
Equity in Ocular Telehealth Management, LLC	699	(22,638)
Interest income	43	66
Interest expense	(82,491)	(81,647)
Total other (expense) and income	(81,749)	(104,219)
Net loss from continuing operations before taxes	(789,649)	(953,406)
Provision for income taxes	0	0
Net loss from continuing operations	(789,649)	(953,406)
Net income from discontinued operations	0	304,244
Net loss	$ (789,649)	$ (649,162)
Net (loss) per share, Basic:
Continuing operations	$ (0.10)	$ (0.13)
Discontinued operations	$ 0.00	$ 0.04
Net loss	$ (0.10)	$ (0.09)
Net (loss) per share, Diluted:
Continuing operations	$ (0.10)	$ (0.13)
Discontinued operations	$ 0.00	$ 0.04
Net loss	$ (0.10)	$ (0.09)
Weighted average shares - basic	7,526,430	7,526,430
Weighted average shares - diluted	7,526,430	7,526,430